We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 6,430 results
  1. Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma

    There is a critical need to identify new therapeutic vulnerabilities in pancreatic ductal adenocarcinoma (PDAC). Transcriptional co-regulators...

    Kranthi Kumar Chougoni, Haemin Park, ... Steven R. Grossman in Oncogenesis
    Article Open access 10 November 2023
  2. Oncogenes, Signal Transduction and the Hallmarks of Cancer

    In this chapter, we will understand that the observation that RNA tumor viruses can transform normal cells into cancer cells led to the discovery of...
    Carsten Carlberg, Eunike Velleuer, Ferdinand Molnár in Molecular Medicine
    Chapter 2023
  3. Promotion of stem cell-like phenotype of lung adenocarcinoma by FAM83A via stabilization of ErbB2

    Lung cancer stands as the leading cause of mortality among all types of tumors, with over 40% of cases being lung adenocarcinoma (LUAD). Family with...

    Ye Yuan, Liang Hao, ... Zhan-Wu Yu in Cell Death & Disease
    Article Open access 28 June 2024
  4. ERBB2 Targeting Reveals a Significant Suppression of Tumorigenesis in Murine Endometrial Cancer with Pten Mutation

    Endometrial cancer is the most common gynecologic malignancy. PTEN is a negative regulator of PI3K signaling and is deficient in > 50% of primary...

    Krystina Dunston, Mark I. Hunter, ... Jae-Wook Jeong in Reproductive Sciences
    Article 18 April 2024
  5. Tumor Progression through Interaction of Mucins with Lectins and Subsequent Signal Transduction

    Glycans bearing on cell surface glycoproteins are often altered in tumor cells. A variety of aberrant glycans, tumor-associated carbohydrate...
    Shungo Iwamoto, Naoki Itano, Hiroshi Nakada in Glycosignals in Cancer
    Chapter 2023
  6. Metformin alleviates ethanol-induced cardiomyocyte injury by activating AKT/Nrf2 signaling in an ErbB2-dependent manner

    Background

    Metformin, a first-line oral anti-diabetic drug, has recently been reported to exert protective effect on various cardiovascular diseases....

    Yunjie Chen, Suyan Zhu, ... Xuan Zhou in Molecular Biology Reports
    Article 11 February 2023
  7. Oncogenes and Signal Transduction

    The observation that RNA tumor viruses, which have captured host genes encoding for key proteins in signal transduction cascades, can transform...
    Carsten Carlberg, Eunike Velleuer in Cancer Biology: How Science Works
    Chapter 2021
  8. Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers

    Chimeric antigen receptor (CAR)-engineered immune effector cells constitute a promising approach for adoptive cancer immunotherapy. Nevertheless,...

    Jordi Pfeifer Serrahima, Congcong Zhang, ... Winfried S. Wels in Cancer Immunology, Immunotherapy
    Article Open access 23 January 2023
  9. Docking protein 6 (DOK6) selectively docks the neurotrophic signaling transduction to restrain peripheral neuropathy

    The appropriate and specific response of nerve cells to various external cues is essential for the establishment and maintenance of neural circuits,...

    Yan Guo, Pan **ang, ... **aozhong Peng in Signal Transduction and Targeted Therapy
    Article Open access 14 February 2024
  10. Glycosylation promotes the cancer regulator EGFR-ErbB2 heterodimer formation — molecular dynamics study

    ErbB family of receptor tyrosine kinases play significant roles in cellular differentiation and proliferation. Mutation or overexpression of these...

    Zahra Motamedi, Hassan Rajabi-Maham, Maryam Azimzadeh Irani in Journal of Molecular Modeling
    Article 24 November 2021
  11. Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test

    Purpose

    Dealing with variants of unknown significance (VUS) is an important issue in the clinical application of NGS-based cancer gene panel tests. We...

    Yohei Harada, Akemi Sato, ... Naoko Sueoka-Aragane in Cellular Oncology
    Article Open access 08 January 2022
  12. Nuclear ErbB2 represses DEPTOR transcription to inhibit autophagy in breast cancer cells

    ErbB2, a classical receptor tyrosine kinase, is frequently overexpressed in breast cancer cells. Although the role of ErbB2 in the transmission of...

    Yanli Bi, Longyuan Gong, ... Yongchao Zhao in Cell Death & Disease
    Article Open access 14 April 2021
  13. Signal Transducer and Activator of Transcription as a Potential Therapeutic Target in Breast Cancer

    Signal transducer and activator of transcription (STAT) signaling pathway, connected upstream with Janus kinases (JAK) proteins, is known to be...
    Niloofar Deravi, Nima Rezaei in
    Chapter 2023
  14. Record the Single Cell Signal Pathway

    Systems biology promises to deliver a holistic time and space understanding of biological processes with applications including the identification of...
    Reference work entry 2022
  15. Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer

    Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are effective against non-small cell lung cancer (NSCLC) with EGFR -activating...

    Shiqi Ma, Lu Zhang, ... Bangrong Cao in Oncogene
    Article 09 March 2021
  16. Ag nanorod@PEI-Ag nanohybrid as an excellent signal label for sensitive and rapid detection of serum HER2

    The accurate detection of Human epidermal growth factor receptor-2 (HER2) as a critical breast cancer biomarker can be essential for the early...

    Fatemeh Hakimian, Mohammad Mazloum-Ardakani in Scientific Reports
    Article Open access 08 December 2023
  17. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of squalene against inflammation

    Squalene (SQ) has been documented in the past for its ability to reduce inflammation, but its mechanism needs more information. In this study, we...

    Shana Sara Luke, M. Naveen Raj, ... N. Prasanth Bhatt in In Silico Pharmacology
    Article 14 May 2024
  18. Oncoinformatic screening of the gene clusters involved in the HER2-positive breast cancer formation along with the in silico pharmacodynamic profiling of selective long-chain omega-3 fatty acids as the metastatic antagonists

    Abstract

    The HER2-positive patients occupy ~ 30% of the total breast cancer patients globally where no prevalent drugs are available to mitigate the...

    A K M Helal Morshed, Salauddin Al Azad, ... Nurunnahar in Molecular Diversity
    Article 29 November 2022
  19. Conformational diversity and protein–protein interfaces in drug repurposing in Ras signaling pathway

    We focus on drug repurposing in the Ras signaling pathway, considering structural similarities of protein–protein interfaces. The interfaces formed...

    Ahenk Zeynep Sayin, Zeynep Abali, ... Ozlem Keskin in Scientific Reports
    Article Open access 12 January 2024
  20. Epithelial–Mesenchymal Transition and Cancer Stem Cells

    Epithelial–mesenchymal transition (EMT), a cellular phenotypic change from epithelial to mesenchymal-like features, is related to the resistance and...
    Chapter 2022
Did you find what you were looking for? Share feedback.